Organization · Venture Capital
BlueStone Venture Partners
BlueStone Venture Partners is a venture capital firm focused on early-stage life science companies in the NATO states (New Mexico, Arizona, Texas, and Oklahoma). They specialize in medical devices, health IT, advanced materials, and molecular diagnostics.
Overview
What BlueStone Venture Partners does
What BlueStone Venture Partners is
BlueStone Venture Partners is a venture capital firm focused on early-stage life science companies in the NATO states (New Mexico, Arizona, Texas, and Oklahoma). They specialize in medical devices, health IT, advanced materials, and molecular diagnostics.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find BlueStone Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
BlueStone Venture Partners as a funder
Investment thesis
BlueStone Venture Partners focuses on investing in life sciences companies in the overlooked 'NATO states' of the Southwest US, leveraging strong local research institutions and best-in-class technology.
Focus narrative
BlueStone Venture Partners invests primarily in life sciences companies, emphasizing sectors where the team has direct experience as both investors and operators. This strategic focus allows them to leverage strong external networks to enhance value for their partners.
Value beyond capital
BlueStone Venture Partners adds value to its portfolio companies through its extensive operational and technical expertise, as well as its strong connections within the healthcare industry and local research institutions.
Terms and economics
- Typical check
- $10,000,000–$50,000,000
Focus and fit
- Stages
- Series A · Series B
- Sectors
- Biotech · Healthcare · Medical Devices · Advanced Materials
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
BlueStone Venture Partners has invested in notable companies such as GT Medical Technologies, which specializes in brain tumor therapies, and BroadSpot Imaging Corporation. The firm currently has a portfolio of 8 companies, focusing on medical devices, health IT, and molecular diagnostics.
Common questions
What to know about BlueStone Venture Partners
Upseed classifies BlueStone Venture Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.